WILMS JORIS (Sr. VP and COO) sold 14.0% of their position (5K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $73.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/27/2024ACC: 0001415889-24-022326
Officer· Sr. VP and COO
Since Sep 2018
-5K
Net shares
Net seller
$73.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5K
Price / share
$14.69
Trade value
$73.45K
% of position
14.0%
8/26/2024
35.60K→30.60K
Total
Net shares
−5K
Net value
-$73.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/26/2024 | S · Sale | −5K | $14.69 | $73.45K | 14.0% | 35.60K | 30.60K |
| Total | −5K | -$73.45K | ||||||
Derivative Transactions0
No derivative transactions reported